SCBIO Adds 10 Life Sciences Industry Leaders to Board of Directors from Across Palmetto State

Staff Report From South Carolina CEO

Monday, February 11th, 2019

Less than two years after initiating a comprehensive relaunch of the state’s official life sciences organization, SCBIO has expanded its Board of Directors for its 501c6 operational entity and added a second 10-member Board for its 501c3 research and educational arm for 2019.  It does so having authored the state’s first-ever life sciences strategic growth plan, conducted an economic impact study validating the contributions of the $11.4 billion industry, tripled revenues and quadrupled membership – all since Spring 2017.

And according to SCBIO President and CEO Sam Konduros, the best and most exciting days for the industry and organization are still ahead of it.

“In a state perhaps best known for building BMWs and Boeing Dreamliners, there is a very strong life sciences story brewing as well, creating opportunities to diversify and accelerate growth of our state’s knowledge economy,” said Konduros recently.  He further cited rapid growth of such national and global brands including Nephron Pharmaceuticals, Arthrex, ZEUS, Abbott, Thorne and AVX as just a few examples of the state’s rapidly rising life sciences industry, which currently spans more than 400 companies in 44 counties and employs over 15,000 well-paid associates.

Leading the policy- and strategy-making efforts of the 501c6 entity of the non-profit organization, the Board of Directors meets regularly to receive updates on SCBIO business objectives, domestic and global initiatives, and to help hone strategies and offer insight.  Nephron Pharmaceuticals Corporation CEO Lou Kennedy will serve as SCBIO’s 2019 Board Chair; Stephanie Yarbrough, Womble Bond Dickinson, LLP as Vice Chair; Michael Rusnak, Medical University of South Carolina Research Foundation as Treasurer; and Josh Ridley of ZEUS as Secretary.

Jeff Stover of Haynsworth Sinkler Boyd, PA will serve as Legal Officer; Heather Simmons Jones of the Greenwood Partnership Alliance as Annual Conference Officer;Bryan Davis of Prisma/Greenville Health System’s Office of Innovations as Healthcare/Innovation Officer; Adam Hoots of DPR Construction as Talent/Workforce Officer; and Sam Konduros, President and CEO of SCBIO.

Recently added members of the SCBIO Board of Directors are:

Mike Briggs – President & CEO, Central SC Alliance

Caroline Brown – Director of External Affairs, Medical University of South Carolina

Thornton Kirby – President & CEO, South Carolina Hospital Association

Adam Klonecke – Senior Site Director, Abbott

Angie Leidinger – VP of External Affairs, Clemson University

Tom McKenna – Chief Operating Officer, Thorne

Robert Ryan – CEO & Founder, Innova Therapeutics

Dave Shalaby – President, Poly-Med, Inc.

Will Williams – President & CEO, Economic Development Partnership (Aiken)

Cynthia Young – Dean, Clemson University College of Science

Returning members of the SCBIO Board for 2019 are:

Mandy Brawley – South Carolina Department of Commerce

Matthew Couvillion – Wyche Law Firm

John J. Darby – Johnson & Johnson Services

Tressa Gardner – SE Institute of Manufacturing & Technology

Mike Graney – Charleston Regional Development Alliance

Chad Hardaway – University of South Carolina Office of Economic Engagement

Will Harms – Blue Cross Blue Shield of SC

Erica Jackson – K&L Gates

Marc Metcalf – Upstate SC Alliance

Kathy Phlegar – Phlegar & Associates

Christine Dixon Thiesing – SCRA

Courtney Warren – Marsh & McLennan Agency

Comprising the smaller Board of SCBIO’s 501c3 research and educational arm are Kathryn Becker of Translational Science Solutions; Michael Bolick of Treis Blockchain; Matthew Couvillion of Wyche Law Firm; Shontavia Johnson of Clemson University; Steve Johnson of SCRA; Chris Przirembel, retired Clemson University executive; Shawn Regan of Rhythmlink; Craig Walker of Hitachi Healthcare Americas; Erica Jackson of K&L Gates; and SCBIO CEO Sam Konduros.